GPT Healthcare

154.00
+6.04
(4.08%)
Market Cap
1,263.64 Cr
EPS
5.22
PE Ratio
25.82
Dividend Yield
2.67 %
52 Week High
208.45
52 Week Low
126.10
PB Ratio
6.13
Debt to Equity
0.76
Sector
Hospitals
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from1 analysts
HOLD
Analysts have suggested that investors can hold this stock
Buy
Buy0.0 %
0.0 %
Hold
Hold+100.00 %
+100.00 %
Sell
Sell0.0 %
0.0 %
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,305.60
#1 1,26,923.49
111.80
7,028.46
18.77
1,070
26.84
67.57
7,561.00
1,08,715.58
75.22
#1 21,794.00
14.74
1,513
60.41
71.42
799.70
60,374.00
70.94
7,782.75
8.99
809
-7.43
64.11
1,997.10
40,812.90
#1 51.49
5,482.98
10.96
807
3.41
55.29
639.10
33,113.11
90.57
4,138.46
22.85
#1 5,417
#1 3,986.36
73.77
1,176.80
31,607.36
61.68
3,692.32
#1 25.09
486
-20.35
54.81
684.00
27,369.50
71.54
3,035.10
12.94
409
48.39
54.22
1,618.10
16,432.08
67.82
1,566.90
17.46
244
10.57
65.83
1,484.10
9,730.65
51.77
1,290.20
17.77
194
-0.88
52.75
564.40
7,868.60
171.69
2,218.14
12.97
28
-71.06
50.26
Forecast
Actual
Growth Rate
Revenue Growth
37.57 %
Net Income Growth
97.63 %
Cash Flow Change
53.50 %
ROE
67.13 %
ROCE
54.46 %
EBITDA Margin (Avg.)
3.97 %

Yearly Financial Results

Annual Financials
2020
2021
2022
TTM
Revenue
216
249
342
0
Expenses
176
194
264
0
EBITDA
40
55
79
0
Operating Profit %
17 %
20 %
22 %
0 %
Depreciation
11
13
14
0
Interest
14
14
11
0
Profit Before Tax
15
29
54
0
Tax
4
8
12
0
Net Profit
11
21
42
0
EPS in ₹
4.11
7.92
5.22
0.00

Balance Sheet

Balance Sheet
2020
2021
2022
Total Assets
309
317
323
Fixed Assets
226
220
220
Current Assets
63
86
86
Capital Work in Progress
2
0
1
Investments
1
1
10
Other Assets
80
97
92
Total Liabilities
309
317
323
Current Liabilities
65
60
69
Non Current Liabilities
117
123
97
Total Equity
127
134
158
Reserve & Surplus
69
76
78
Share Capital
18
18
80

Cash Flow

Cash Flow
2020
2021
2022
Net Cash Flow
-1
4
4
Investing Activities
-54
-17
-5
Operating Activities
42
43
66
Financing Activities
12
-22
-57

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5 3.5 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.84 2.38 0.00

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
05 Aug 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
05 Aug 2025 155.81 148.00
29 Jul 2025 DIVIDEND Dividend
₹ 1.50 /share
29 Jul 2025 155.81 148.00
23 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
23 May 2025 159.15 155.81
11 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
11 Feb 2025 174.05 152.66
28 Nov 2024 DIVIDEND Dividend
₹ 1.00 /share
28 Nov 2024 163.80 176.65
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 172.95 163.80
25 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
25 Jul 2024 165.10 168.15
18 Jul 2024 DIVIDEND Dividend
₹ 1.50 /share
18 Jul 2024 165.10 175.27
02 Apr 2024 DIVIDEND Dividend
₹ 1.00 /share
02 Apr 2024 167.70 182.90

Announcements

Closure of Trading Window7 days ago
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 24, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 24, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 23, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 23, 2025
Corporate Action-Board approves DividendMay 23, 2025
Corporate Action-Fixes Book Closure For 36Th Annual General Meeting.May 23, 2025
Results-Financial Results For The Q4FY2025May 23, 2025
Board Meeting Outcome for Board Meeting Outcome Held On May 23 2025May 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Considering Inter Alia Audited Financial Results For The Quarter And Year Ended March 31 2025.May 14, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)May 11, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)May 02, 2025
Intimation Under Regulation 30 Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015 (LODR Regulations)-Change In The Correspondence Details Of Registrar And Share Transfer Agent (RTA) Of The CompanyApr 18, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2025
Announcement Under Regulation 30 Of SEBI (LODR) Regulations 2015Mar 28, 2025
Closure of Trading WindowMar 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 21, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 12, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 12, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 11, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 11, 2025
Integrated Filing (Financial)Feb 11, 2025
Results-Financial Results For The 3Rd Quarter Ended December 31 2024.Feb 11, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Dated February 11 2025.Feb 11, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 07, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone) Along With Limited Review Report Of The Statutory Auditor Thereon Of The Company For The 3Rd QuarterJan 22, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 13, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 03, 2025
Closure of Trading WindowDec 27, 2024
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 05, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 21, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 19, 2024
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 16, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 15, 2024
Announcement under Regulation 30 (LODR)-Investor PresentationNov 14, 2024
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 14, 2024
Corporate Action-Board approves DividendNov 14, 2024
Results-Financial Results For 2Nd Quarter And Half Year Ended September 30, 2024Nov 14, 2024
Board Meeting Outcome for Q2FY25 ResultsNov 14, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 06, 2024
Board Meeting Intimation for Considering Inter Alia And Approving The Unaudited Financial Results (Standalone) Of The Company For The 2Nd Quarter And Half Year Ended On September 30, 2024 And To Declare Interim Dividend For The Financial Year 2024-25.Nov 04, 2024
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Oct 14, 2024
Closure of Trading WindowSep 27, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 29, 2024
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 22, 2024
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 16, 2024

Technical Indicators

RSI(14)
Neutral
49.23
ATR(14)
Volatile
4.73
STOCH(9,6)
Neutral
41.87
STOCH RSI(14)
Neutral
46.82
MACD(12,26)
Bullish
0.04
ADX(14)
Weak Trend
20.95
UO(9)
Bearish
44.09
ROC(12)
Downtrend And Accelerating
-1.97
WillR(14)
Neutral
-48.45

Mutual Fund Holdings